Genofre, Eduardo
Carstens, Donna
DeBacker, Wilfried
Muchmore, Patrick
Panettieri, Reynold A. Jr
Rhodes, Kirsty
Shih, Vivian H.
Trudo, Frank
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach
https://doi.org/10.1186/s12931-023-02415-4
Article History
Received: 21 November 2022
Accepted: 4 April 2023
First Online: 3 May 2023
Declarations
:
: The study will be performed in accordance with ethical principles that have their origin in the Declaration of Helsinki and are consistent with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and Good Clinical Practice (ICH/GCP) and applicable regulatory requirements.
: Not applicable.
: EG, DC, KR, VHS, FT: Are or were employees of AstraZeneca at the time of study design, may own stock or stock options. PM: Employee of FLUIDDA. WDB: Medical advisor for FLUIDDA. RP Jr: Has received research support from, and conducted advisory boards for, AstraZeneca, Sanofi, Regeneron, Genentech, and Novartis.